Usana Health Sciences Inc’s filing revealed that its Director Fleming John Turman unloaded Company’s shares for reported $14829.0 on Jun 09 ’25. In the deal valued at $29.66 per share,500 shares were sold. As a result of this transaction, Fleming John Turman now holds 4,200 shares worth roughly $0.13 million.
Then, Noot Walter sold 6,291 shares, generating $190,568 in total proceeds. Upon selling the shares at $30.29, the CHIEF OPERATING OFFICER now owns 0 shares.
Before that, WALTER NOOT bought 6,291 shares. Usana Health Sciences Inc shares valued at $190,567 were divested by the Officer at a price of $30.29 per share.
Sidoti initiated its Usana Health Sciences Inc [USNA] rating to a Buy in a research note published recently. A number of analysts have revised their coverage, including Jefferies’s analysts, who decreased its forecast for the stock in early July from “a Hold” to “an Underperform”. DA Davidson began covering USNA with “Neutral” recommendation on April 14, 2022. ROTH Capital started covering the stock on December 17, 2020. It rated USNA as “a Buy”.
Price Performance Review of USNA
On Tuesday, Usana Health Sciences Inc [NYSE:USNA] saw its stock fall -1.30% to $30.45. Over the last five days, the stock has lost -1.33%. Usana Health Sciences Inc shares have fallen nearly -15.16% since the year began. Nevertheless, the stocks have fallen -32.91% over the past one year. While a 52-week high of $48.85 was reached on 01/02/25, a 52-week low of $23.10 was recorded on 04/21/25.
Levels Of Support And Resistance For USNA Stock
The 24-hour chart illustrates a support level at 30.23, which if violated will result in even more drops to 30.00. On the upside, there is a resistance level at 30.68. A further resistance level may holdings at 30.90.
The most recent change occurred on August 22, 2019 when Jefferies began covering the stock and recommended ‘”a Hold”‘ rating along with a $65 price target.
